Metraipolis › archive › dc_9bc52facef63

Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case report — Europe PMC PMID:42460058

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42460058
DOI: 10.3389/fmed.2026.1878696
License (as archived): solo-consultazione
Archived: 2026-10-18T13:42:15.840Z
SHA-256 of the archived text: e96929a438de61f3aea9676c34a74cfd3a1221525ab6c09d7e55f942d0f31328
Stable URL of this page: https://metraipolis.com/documento/dc_9bc52facef63

How to cite

Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case report — Europe PMC PMID:42460058 — Europe PMC (en), https://europepmc.org/article/MED/42460058 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9bc52facef63 (Metraipolis archive dc_9bc52facef63, sha256 e96929a438de61f3aea9676c34a74cfd3a1221525ab6c09d7e55f942d0f31328)

BibTeX

@misc{dc9bc52facef63,
  title = {Rechallenge of ruxolitinib after momelotinib-related toxicity in a 74-yo woman with secondary myelofibrosis: a case report — Europe PMC PMID:42460058},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42460058},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9bc52facef63; sha256 e96929a438de61f3aea9676c34a74cfd3a1221525ab6c09d7e55f942d0f31328},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42460058. Agents can read the archived copy with the MCP tool read_document.